Selected research
Industry Research
Tissue Heart Valves Device Industry Research Report 2026
Market perspective
The global Tissue Heart Valves Device market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Tissue Heart Valves Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Tissue Heart Valves Device is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Tissue Heart Valves Device is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Tissue Heart Valves Device include Boston Scientific Corporation, Comed BV, CryoLife, Edward Lifesciences Corporation, JenaValve Technology Inc, Meril Life Sciences, On-X Life Technologies, Inc, Sorin Group and TTK Healthcare Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Tissue Heart Valves Device market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Tissue Heart Valves Device Market by Company
Boston Scientific Corporation
Comed BV
CryoLife
Edward Lifesciences Corporation
JenaValve Technology Inc
Meril Life Sciences
On-X Life Technologies, Inc
Sorin Group
TTK Healthcare Limited
Beijing Balance Medical Technology Co., Ltd
Medtronic
Abbott
Tissue Heart Valves Device Segment by Type
Aortic Valve
Tricuspid Valve
Pulmonary Valve
Mitral Valve
Tissue Heart Valves Device Segment by Application
Ambulatory Surgical Centers
Hospitals
Clinics
Tissue Heart Valves Device Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tissue Heart Valves Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tissue Heart Valves Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tissue Heart Valves Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Tissue Heart Valves Device manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Tissue Heart Valves Device by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Tissue Heart Valves Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Aortic Valve
- Tricuspid Valve
- Pulmonary Valve
- Mitral Valve
Applications
- Ambulatory Surgical Centers
- Hospitals
- Clinics
Companies covered
- Boston Scientific Corporation
- Comed BV
- CryoLife
- Edward Lifesciences Corporation
- JenaValve Technology Inc
- Meril Life Sciences
- On-X Life Technologies, Inc
- Sorin Group
- TTK Healthcare Limited
- Beijing Balance Medical Technology Co., Ltd
- Medtronic
- Abbott
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Tissue Heart Valves Device Market Size (2021-2032)
- 2.2.2 Global Tissue Heart Valves Device Sales (2021-2032)
- 2.2.3 Global Tissue Heart Valves Device Market Average Price (2021-2032)
- 2.3 Tissue Heart Valves Device by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Aortic Valve
- 2.3.3 Tricuspid Valve
- 2.3.4 Pulmonary Valve
- 2.3.5 Mitral Valve
- 2.4 Tissue Heart Valves Device by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Ambulatory Surgical Centers
- 2.4.3 Hospitals
- 2.4.4 Clinics
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Tissue Heart Valves Device Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Tissue Heart Valves Device Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Tissue Heart Valves Device Revenue of Manufacturers (2021-2026)
- 3.4 Global Tissue Heart Valves Device Average Price by Manufacturers (2021-2026)
- 3.5 Global Tissue Heart Valves Device Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Tissue Heart Valves Device, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Tissue Heart Valves Device, Product Type & Application
- 3.8 Global Manufacturers of Tissue Heart Valves Device, Established Date
- 3.9 Global Tissue Heart Valves Device Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Boston Scientific Corporation
- 4.1.1 Boston Scientific Corporation Company Information
- 4.1.2 Boston Scientific Corporation Business Overview
- 4.1.3 Boston Scientific Corporation Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Boston Scientific Corporation Tissue Heart Valves Device Product Portfolio
- 4.1.5 Boston Scientific Corporation Recent Developments
- 4.2 Comed BV
- 4.2.1 Comed BV Company Information
- 4.2.2 Comed BV Business Overview
- 4.2.3 Comed BV Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Comed BV Tissue Heart Valves Device Product Portfolio
- 4.2.5 Comed BV Recent Developments
- 4.3 CryoLife
- 4.3.1 CryoLife Company Information
- 4.3.2 CryoLife Business Overview
- 4.3.3 CryoLife Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 CryoLife Tissue Heart Valves Device Product Portfolio
- 4.3.5 CryoLife Recent Developments
- 4.4 Edward Lifesciences Corporation
- 4.4.1 Edward Lifesciences Corporation Company Information
- 4.4.2 Edward Lifesciences Corporation Business Overview
- 4.4.3 Edward Lifesciences Corporation Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Edward Lifesciences Corporation Tissue Heart Valves Device Product Portfolio
- 4.4.5 Edward Lifesciences Corporation Recent Developments
- 4.5 JenaValve Technology Inc
- 4.5.1 JenaValve Technology Inc Company Information
- 4.5.2 JenaValve Technology Inc Business Overview
- 4.5.3 JenaValve Technology Inc Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 JenaValve Technology Inc Tissue Heart Valves Device Product Portfolio
- 4.5.5 JenaValve Technology Inc Recent Developments
- 4.6 Meril Life Sciences
- 4.6.1 Meril Life Sciences Company Information
- 4.6.2 Meril Life Sciences Business Overview
- 4.6.3 Meril Life Sciences Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Meril Life Sciences Tissue Heart Valves Device Product Portfolio
- 4.6.5 Meril Life Sciences Recent Developments
- 4.7 On-X Life Technologies, Inc
- 4.7.1 On-X Life Technologies, Inc Company Information
- 4.7.2 On-X Life Technologies, Inc Business Overview
- 4.7.3 On-X Life Technologies, Inc Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 On-X Life Technologies, Inc Tissue Heart Valves Device Product Portfolio
- 4.7.5 On-X Life Technologies, Inc Recent Developments
- 4.8 Sorin Group
- 4.8.1 Sorin Group Company Information
- 4.8.2 Sorin Group Business Overview
- 4.8.3 Sorin Group Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sorin Group Tissue Heart Valves Device Product Portfolio
- 4.8.5 Sorin Group Recent Developments
- 4.9 TTK Healthcare Limited
- 4.9.1 TTK Healthcare Limited Company Information
- 4.9.2 TTK Healthcare Limited Business Overview
- 4.9.3 TTK Healthcare Limited Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 TTK Healthcare Limited Tissue Heart Valves Device Product Portfolio
- 4.9.5 TTK Healthcare Limited Recent Developments
- 4.10 Beijing Balance Medical Technology Co., Ltd
- 4.10.1 Beijing Balance Medical Technology Co., Ltd Company Information
- 4.10.2 Beijing Balance Medical Technology Co., Ltd Business Overview
- 4.10.3 Beijing Balance Medical Technology Co., Ltd Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Beijing Balance Medical Technology Co., Ltd Tissue Heart Valves Device Product Portfolio
- 4.10.5 Beijing Balance Medical Technology Co., Ltd Recent Developments
- 4.11 Medtronic
- 4.11.1 Medtronic Company Information
- 4.11.2 Medtronic Business Overview
- 4.11.3 Medtronic Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Medtronic Tissue Heart Valves Device Product Portfolio
- 4.11.5 Medtronic Recent Developments
- 4.12 Abbott
- 4.12.1 Abbott Company Information
- 4.12.2 Abbott Business Overview
- 4.12.3 Abbott Tissue Heart Valves Device Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Abbott Tissue Heart Valves Device Product Portfolio
- 4.12.5 Abbott Recent Developments
5 Global Tissue Heart Valves Device Market Scenario by Region
- 5.1 Global Tissue Heart Valves Device Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Tissue Heart Valves Device Sales by Region: 2021-2032
- 5.2.1 Global Tissue Heart Valves Device Sales by Region: 2021-2026
- 5.2.2 Global Tissue Heart Valves Device Sales by Region: 2027-2032
- 5.3 Global Tissue Heart Valves Device Revenue by Region: 2021-2032
- 5.3.1 Global Tissue Heart Valves Device Revenue by Region: 2021-2026
- 5.3.2 Global Tissue Heart Valves Device Revenue by Region: 2027-2032
- 5.4 North America Tissue Heart Valves Device Market Facts & Figures by Country
- 5.4.1 North America Tissue Heart Valves Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Tissue Heart Valves Device Sales by Country (2021-2032)
- 5.4.3 North America Tissue Heart Valves Device Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Tissue Heart Valves Device Market Facts & Figures by Country
- 5.5.1 Europe Tissue Heart Valves Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Tissue Heart Valves Device Sales by Country (2021-2032)
- 5.5.3 Europe Tissue Heart Valves Device Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Tissue Heart Valves Device Market Facts & Figures by Country
- 5.6.1 Asia Pacific Tissue Heart Valves Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Tissue Heart Valves Device Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Tissue Heart Valves Device Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Tissue Heart Valves Device Market Facts & Figures by Country
- 5.7.1 South America Tissue Heart Valves Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Tissue Heart Valves Device Sales by Country (2021-2032)
- 5.7.3 South America Tissue Heart Valves Device Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Tissue Heart Valves Device Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Tissue Heart Valves Device Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Tissue Heart Valves Device Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Tissue Heart Valves Device Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Tissue Heart Valves Device Sales by Type (2021-2032)
- 6.1.1 Global Tissue Heart Valves Device Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Tissue Heart Valves Device Sales Market Share by Type (2021-2032)
- 6.2 Global Tissue Heart Valves Device Revenue by Type (2021-2032)
- 6.2.1 Global Tissue Heart Valves Device Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Tissue Heart Valves Device Revenue Market Share by Type (2021-2032)
- 6.3 Global Tissue Heart Valves Device Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Tissue Heart Valves Device Sales by Application (2021-2032)
- 7.1.1 Global Tissue Heart Valves Device Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Tissue Heart Valves Device Sales Market Share by Application (2021-2032)
- 7.2 Global Tissue Heart Valves Device Revenue by Application (2021-2032)
- 7.2.1 Global Tissue Heart Valves Device Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Tissue Heart Valves Device Revenue Market Share by Application (2021-2032)
- 7.3 Global Tissue Heart Valves Device Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Tissue Heart Valves Device Value Chain Analysis
- 8.1.1 Tissue Heart Valves Device Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Tissue Heart Valves Device Production Mode & Process
- 8.2 Tissue Heart Valves Device Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Tissue Heart Valves Device Distributors
- 8.2.3 Tissue Heart Valves Device Customers
9 Global Tissue Heart Valves Device Analyzing Market Dynamics
- 9.1 Tissue Heart Valves Device Industry Trends
- 9.2 Tissue Heart Valves Device Industry Drivers
- 9.3 Tissue Heart Valves Device Industry Opportunities and Challenges
- 9.4 Tissue Heart Valves Device Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst